Chronic Plaque Psoriasis Completed Phase 2 Trials for Adalimumab (DB00051)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033442 (Chronic Plaque Psoriasis) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01872546 | Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy |